OR WAIT null SECS
September 07, 2022
A new survey has demonstrated that remote audits, brought to the fore thanks to COVID-19, are not necessarily a preferred option for clients.
September 06, 2022
Hovione has expanded its drug product offering with a new manufacturing line dedicated to continuous tableting.
September 02, 2022
Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to expand its sickle cell and rare blood disorder portfolio.
FDA has issued an emergency use authorization for both the Pfizer-BioNTech and Moderna bivalent COVID-19 boosters.
Bio-Rad’s new antibodies are designed to develop highly selective pharmacokinetic (PK) and anti-drug antibody (ADA) assays for evolocumab and its biosimilars.
Roche’s Digital LightCycler System is designed to aid in diagnostics for cancer, genetic disease, and infection.
More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.
As winter approaches, the next generation of COVID-19 vaccines are being prepared and scheduled, ready for distribution across Europe and the world.
While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.
August 31, 2022
Lonza has introduced X-ray powder diffraction capability at its Monteggio, Switzerland site.